News

Artificial intelligence is no longer a speculative force in medicine. It is already embedded in everyday care. AI systems flag hospitalized patients at risk of deterioration, assist radiologists reading mammograms, draft clinicians’ notes, route patient messages, and increasingly interact directly with patients through chatbots and digital assistants.

As the popularity of Ozempic, Wegovy, and other GLP-1 receptor agonists skyrockets, so too do the questions surrounding their safety. Initially designed to treat type 2 diabetes, GLP-1 drugs are known to alter body composition, reducing fat mass but also affecting lean muscle. In the ICU, where patients already experience severe metabolic stress and muscle breakdown, clinicians have worried that these medications might quietly worsen outcomes.

A Stanford-led trial shows that a five-day-a-month fasting-mimicking diet may reduce symptoms and inflammation in adults with mild to moderate Crohn’s disease.

Infectious disease expert Marc Lipsitch reflects on pandemic lessons, science communication, and his next chapter at Stanford.

Stanford’s Division of Computational Medicine launches a new identity, showcasing its data-driven tools, AI innovation, and impact on clinical care.

Looking back on the year, Stanford’s Department of Medicine advanced groundbreaking research, elevated patient care, and strengthened our community.

New Stanford Department of Medicine podcast, The Future of Everything, engages the thought leaders who are reshaping how we understand disease, deliver care, and imagine what's possible in human health.

Through expert interviews and clear, engaging updates, the DoM's Communications Team breaks down complex discoveries from Stanford Department of Medicine – bringing you the latest breakthroughs in accessible terms.

Stanford’s William Robinson, MD, and his team have revealed how the Epstein-Barr virus reprograms immune cells to set off lupus—cracking one of immunology’s longest-standing mysteries.

At Stanford’s Department of Medicine Grand Rounds, Sumbul Desai, MD, Apple’s VP of Health & Stanford professor traced the long arc from bedside lessons to products that may change care for millions.